General Information of the Compound
| Compound ID |
CP0410672
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3aR,7aR)-1-[1-(1,2,3,4,4a,5,6,7,8,8a-decahydronaphthalen-2-yl)piperidin-4-yl]-3-ethyl-3a,4,5,6,7,7a-hexahydrobenzimidazol-2-one
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H41N3O
|
||||||||||||||||||
| Molecular Weight |
387.612
|
||||||||||||||||||
| Canonical SMILES |
CCN1[C@@H]2CCCC[C@H]2N(C2CCN(CC2)C2CCC3CCCCC3C2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H41N3O/c1-2-26-22-9-5-6-10-23(22)27(24(26)28)20-13-15-25(16-14-20)21-12-11-18-7-3-4-8-19(18)17-21/h18-23H,2-17H2,1H3/t18?,19?,21?,22-,23-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AEGKEQPSPQTHKK-HSJBNPAXSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01515, Mu-type opioid receptor
Protein ID: PT01360, Nociceptin receptor